非酒精性脂肪性肝病治疗药物研究进展(4)
[10] Ratziu V， Harrison SA， Francque S， et al. Elafibranor， an agonist of the peroxisome proliferator-activated receptor-αand -δ， induces resolution of nonalcoholic steatohepatitis without fibrosis worsening [J]. Gastroenterology， 2016， 150(5)： 1147-1159.e5.[11] Jain MR， Giri SR， Bhoi B， et al. Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models [J]. Liver Int ......
您现在查看是摘要页，全文长 3246 字符。